Trials / Completed
CompletedNCT00514657
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 (Randomised Controlled Phase II Clinical Trial)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- Kaken Pharmaceutical · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The present clinical trial clarified that basic fibroblast growth factor-2 (FGF-2) can induce regeneration of periodontal tissue lost by progression of periodontitis and evaluated the safety of such induction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trafermin (genetical recombinant of human basic Fibroblast Growth Factor) |
Timeline
- Start date
- 2001-12-01
- Completion
- 2004-02-01
- First posted
- 2007-08-10
- Last updated
- 2007-08-10
Source: ClinicalTrials.gov record NCT00514657. Inclusion in this directory is not an endorsement.